Aegicare is an AI-driven platform that provides clinical whole-genome sequencing solutions, utilizing proprietary bioinformatics tools to deliver precise genetic analysis and rare disease interpretation. The platform addresses the challenge of accurate diagnosis in complex genetic conditions, enhancing patient care through tailored genomic insights.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing rare diseases is challenging due to the complexity of genetic conditions and the difficulty in accurately interpreting genomic data. Traditional methods often lack the precision needed for effective diagnosis and personalized treatment plans.
Solution
Aegicare offers clinical whole-genome sequencing solutions powered by AI to improve the accuracy and speed of rare disease diagnosis. Their platform utilizes proprietary bioinformatics tools, including the WEAVER™ biological information analysis system, to provide precise genetic analysis and interpretation. By leveraging a knowledge graph of multi-omics data from a large cohort of Chinese patients with rare diseases, Aegicare delivers tailored genomic insights to enhance patient care. The AEGIS™ gene intelligence platform helps clinicians make informed decisions based on comprehensive genomic data.
Target Audience
Aegicare's primary customers include hospitals, medical institutions, and research organizations focused on the diagnosis and treatment of rare diseases.
Features
- AI-powered analysis of whole-genome sequencing data for clinical applications
- Proprietary WEAVER™ bioinformatics system for accurate variant calling and annotation
- Comprehensive knowledge graph of multi-omics data from Chinese rare disease patients
- Identification of structural variations, including chromosomal translocations
- Support for the diagnosis of complex genetic conditions, including leukemia in patients with Down syndrome
- Clinical reporting with tailored genomic insights for personalized treatment plans